● Round also saw participation from notable investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited ● Company turned profitable in Q2 FY24-25 and crossed Rs. 100 Cr net revenue ARR in Q3 ● Company aims to clock Rs. 150 Cr net revenue ARR in the next quarter. ● Funds raised will be deployed for retail expansion and new product introduction across key channels ...
The strategic acquisition enhances Telix’s next-generation radiopharmaceutical capabilities, strengthening its position in precision oncology and beyond....
The funding will help scale access to telehealth-based opioid use disorder care across the U.S., improving patient reach and support....
The acquisition aims to strengthen Zimmer Biomet’s position in the foot and ankle surgery market with Paragon 28’s specialized solutions....
Unlocking growing investment opportunities in innovative healthcare solutions. ...
Largest Primary Fundraise in Indian Diagnostics Sector Fuels Personalized Medicine, Expansion Strategy, and IPO Aspirations...
Exploring transformative potential of AI infrastructure in advancing medical research and treatments. ...
Revolutionizing wound diagnostics with AI-powered technology while delivering exceptional financial performance....
Three-year agreement reinforces commitment to improving rabies and varicella care across the region. ...
Promising treatment for gastrointestinal cancers aims to set new standards in precision oncology....
